Home
/
Xeris Biopharma Holdings, Inc.
/
Financials
/
Quarterly
Xeris Biopharma Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Xeris Biopharma Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2022
Mar 31, 2022
$22.07M
May 11, 2022
Q1
2022
Mar 31, 2021
$8.20M
May 11, 2022
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$74.38M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$71.54M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$60.12M
May 8, 2025
Q3
2025
Sep 30, 2024
$54.27M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$48.07M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$40.64M
May 8, 2025
Q3
2024
Sep 30, 2023
$48.32M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$38.01M
Aug 8, 2024
Q3
2023
Sep 30, 2022
$29.73M
Nov 9, 2023
Q2
2022
Jun 30, 2022
$25.31M
Aug 10, 2022
Q1
2022
Mar 31, 2022
$21.91M
May 11, 2022
Q3
2022
Sep 30, 2021
$11.06M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$8.91M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$8.05M
May 11, 2022
Q3
2021
Sep 30, 2020
$9.40M
Nov 10, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$621.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
($1.93M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($1.93M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($9.22M)
May 8, 2025
Q2
2025
Mar 31, 2025
($9.22M)
Aug 7, 2025
Q3
2025
Mar 31, 2025
($9.22M)
Nov 6, 2025
Q3
2025
Sep 30, 2024
($15.74M)
Nov 6, 2025
Q3
2025
Jun 30, 2024
($15.01M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($15.01M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($18.98M)
Nov 6, 2025
Q1
2025
Mar 31, 2024
($18.98M)
May 8, 2025
Q2
2025
Mar 31, 2024
($18.98M)
Aug 7, 2025
Q3
2024
Sep 30, 2023
($12.19M)
Nov 8, 2024
Q3
2024
Jun 30, 2023
($19.84M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($19.84M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($16.83M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($16.83M)
Nov 8, 2024
Q3
2023
Sep 30, 2022
($21.83M)
Nov 9, 2023
Q2
2022
Jun 30, 2022
($26.19M)
Aug 10, 2022
Q3
2023
Jun 30, 2022
($26.19M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$6.73M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$4.48M
Aug 7, 2025
Q1
2025
Mar 31, 2025
($3.09M)
May 8, 2025
Q3
2025
Sep 30, 2024
($12.89M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($8.19M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($14.25M)
May 8, 2025
Q3
2024
Sep 30, 2023
($4.91M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($15.98M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($18.78M)
Nov 9, 2023
Q2
2022
Jun 30, 2022
($18.92M)
Aug 10, 2022
Q1
2022
Mar 31, 2022
($29.07M)
May 11, 2022
Q3
2022
Sep 30, 2021
($24.36M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($25.79M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($16.74M)
May 11, 2022
Q3
2021
Sep 30, 2020
($13.74M)
Nov 10, 2021